XBIOTECH INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
XBIOTECH INC. (XBIT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $1.80 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-08-13
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2026-06-30 was $1.80.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2026-03-31 was $1.78, a 39.25% decline year-over-year.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2025-09-30 was $2.60, a 46.06% decline year-over-year.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $2.68, a 32.32% decline from fiscal 2024.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $3.96, a 37.02% increase from fiscal 2023.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $2.89, a 41.26% decline from fiscal 2022.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $4.92, a 47.04% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.80 10-Q · filed 2026-08-13 | $1.78 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | $1.78 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | $2.68 10-K · filed 2026-03-13 | |||
| 2025-09-30 | $2.60 10-Q · filed 2025-11-12 | $2.92 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 | $2.93 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | $2.93 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | $3.96 10-K · filed 2026-03-13 | |||
| 2024-09-30 | $4.82 10-Q · filed 2025-11-12 | $3.87 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $3.84 10-Q · filed 2025-08-13 | $3.85 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $3.91 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | $2.89 10-K · filed 2025-03-18 | |||
| 2023-09-30 | $3.62 10-Q · filed 2024-11-13 | $2.89 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $6.00 10-Q · filed 2024-08-12 | $4.11 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | $3.84 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | $4.92 10-K · filed 2024-03-15 | |||
| 2022-09-30 | $3.71 10-Q · filed 2023-11-09 | $4.93 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $5.43 10-Q · filed 2023-08-11 | $5.53 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | $7.14 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | $9.29 10-K · filed 2023-03-15 | |||
| 2021-09-30 | $16.17 10-Q · filed 2022-11-09 | $16.69 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | $11.12 10-Q · filed 2022-08-10 | $11.49 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | $13.82 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $12.23 10-K · filed 2022-03-15 | |||
| 2020-09-30 | $12.46 10-Q · filed 2021-11-09 | $12.05 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $14.02 10-Q · filed 2021-08-09 | $14.88 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $12.08 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | $9.36 10-K · filed 2022-03-15 | |||
| 2019-09-30 | $5.66 10-Q · filed 2020-11-09 | $5.14 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | $5.56 10-Q · filed 2020-08-10 | $4.99 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $3.92 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | $4.32 10-K · filed 2021-03-16 | |||
| 2018-09-30 | $3.77 10-Q · filed 2019-11-12 | $4.45 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $4.52 10-Q · filed 2019-08-09 | $4.53 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $3.02 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $4.85 10-K · filed 2020-03-16 | |||
| 2017-09-30 | $4.86 10-Q · filed 2018-10-31 | $4.85 10-Q · filed 2018-10-31 | ||
| 2017-06-30 | $4.66 10-Q · filed 2018-08-09 | $4.85 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $8.24 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | $7.29 10-K/A · filed 2019-03-15 | |||
| 2016-09-30 | $8.50 10-Q · filed 2017-11-09 | $7.09 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $8.17 10-Q · filed 2017-08-08 | $6.64 10-Q · filed 2017-08-08 | ||
| 2016-03-31 | $8.01 10-Q · filed 2017-05-10 | |||
| 2015-12-31 | $17.95 10-K · filed 2018-03-16 | |||
| 2015-09-30 | $16.91 10-Q · filed 2016-11-14 | $17.99 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | $13.01 10-Q · filed 2016-08-12 | $11.49 10-Q · filed 2016-08-12 | ||
| 2015-03-31 | $9.56 10-Q · filed 2015-06-18 | |||
| 2014-12-31 | $8.23 10-K · filed 2017-03-16 | |||
| 2014-03-31 | $7.14 10-Q · filed 2015-06-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |